ALKBH5 and neoplasm: ALKBH5 knockdown has been shown to sensitize melanoma and colon cancer to overcome the resistance for immunotherapy through downregulating prominent cells (Tregs and MDSCs), which immunosuppresses the anti-tumor immunity, while at the same time upregulating DCs (82).